Study of SIR2501 in Solid Tumor Patients Receiving Paclitaxel

Clinical trial NCT07765446 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07765446
Sponsor: Sironax USA, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy

Start date: 2026-08-03
Primary completion: 2027-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.